# Stage 5 — Take action. After acute stabilization of neuroleptic malignant syndrome caused by haloperidol, the client's temperature and rigidity are improving, but auditory hallucinations persist. The psychiatry and medical teams meet with the client and family to plan future antipsychotic treatment. Which elements should the nurse support in the recurrence-prevention plan? Select all that apply.

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=617238&lang=en  
> language: en  
> subject: Health Promotion/Disease Prevention  
> category: HPM

## Question

Stage 5 — Take action. After acute stabilization of neuroleptic malignant syndrome caused by haloperidol, the client's temperature and rigidity are improving, but auditory hallucinations persist. The psychiatry and medical teams meet with the client and family to plan future antipsychotic treatment. Which elements should the nurse support in the recurrence-prevention plan? Select all that apply.

1

Use a long-acting injectable antipsychotic to secure adherence

2

Delay any antipsychotic until at least 2 weeks after symptoms resolve

3

Stay well hydrated; monitor temperature and vitals during any restart

4

Add lithium so that a lower antipsychotic dose controls the psychosis

5

Give benztropine with the first restart dose to prevent new rigidity

6

Choose a low dose of a lower-potency agent and increase it slowly

## Explanation

When psychosis requires antipsychotic rechallenge after NMS, recurrence risk is lowered by waiting at least 2 weeks after resolution, starting a low dose of a lower-potency agent with slow titration, and maintaining hydration with close monitoring of temperature and vital signs. A long-acting injectable cannot be withdrawn if NMS recurs, adding lithium is itself a recognized NMS risk factor, and benztropine prophylaxis targets extrapyramidal symptoms, not NMS, while impairing heat loss.

## In-depth explanation

Quick answer
Support a delay of at least 2 weeks after resolution, a low-dose lower-potency agent titrated slowly, and hydration with temperature and vital-sign monitoring during any restart (2, 3, 6).

Why this is correct
Most clients who need antipsychotics after NMS can be rechallenged safely if risk factors are controlled. Recurrence risk is highest with early rechallenge, high-potency agents, rapid dose escalation, parenteral or depot routes, and dehydration, which are the exact factors present when this client's NMS began (repeated IM doses, rapid escalation, poor intake).

Easy analogy or mental picture
Think of re-entering cold water after a cramp: you wait until the muscle has fully recovered, go in slowly and shallowly, and have someone watching.

Memory hook
Rechallenge rule: Wait, go Weak (low potency), go Slow, stay Wet.

NCLEX decision rule
Plan antipsychotic rechallenge by reversing the risk factors that caused the original episode: timing, potency, rate of escalation, route, and hydration.

Why the other choices are wrong
A long-acting injectable is tempting because adherence matters in psychosis, but a depot cannot be withdrawn if NMS recurs, so oral agents are used for rechallenge. Adding lithium sounds like a dose-sparing strategy, but concurrent lithium is a recognized risk factor for NMS and does not make rechallenge safer. Benztropine with the first dose is tempting because anticholinergics prevent antipsychotic dystonia and EPS rigidity, but they do not prevent NMS and their anticholinergic effect reduces sweating and heat loss.

References
1StatPearls: Neuroleptic Malignant Syndrome (NCBI Bookshelf)Rechallenge after NMS: wait at least 2 weeks, use low-potency or atypical agents at low dose with slow titration, avoid depot forms, maintain hydration, and monitor

## Clinical scenario

Case update
After acute stabilization, the client and family begin planning psychiatric treatment and medical follow-up.

## Key concepts

- **Antipsychotic rechallenge** — Planned reintroduction of an antipsychotic after NMS under conditions that reduce the chance of recurrence.
- **Antipsychotic potency** — The strength of dopamine D2 blockade; high-potency agents such as haloperidol carry greater NMS risk.
- **Long-acting injectable** — A depot antipsychotic released over weeks that cannot be quickly removed if an adverse reaction develops.

## Related questions

- [A 6-month-old infant is brought to the well-child clinic for routine vaccinations. The par…](https://mymerci.kr/pages/nclex_q.php?qn_id=363351&lang=en)
- [A 70-year-old adult with COPD has no prior RSV vaccine and an unknown pneumococcal conjuga…](https://mymerci.kr/pages/nclex_q.php?qn_id=393386&lang=en)
- [A client who may become pregnant asks how to reduce the risk for neural tube defects. Whic…](https://mymerci.kr/pages/nclex_q.php?qn_id=393684&lang=en)
- [The nurse teaches new parents about safe sleep for a 2-month-old infant. Which statement b…](https://mymerci.kr/pages/nclex_q.php?qn_id=394028&lang=en)
- [A pregnant client asks whether an inactivated influenza vaccine is recommended during preg…](https://mymerci.kr/pages/nclex_q.php?qn_id=394095&lang=en)
- [A client asks how to notice possible breast changes between routine screening visits. Whic…](https://mymerci.kr/pages/nclex_q.php?qn_id=394127&lang=en)
- [A client who smokes says, "I know smoking is bad, but I am not ready to quit." Which respo…](https://mymerci.kr/pages/nclex_q.php?qn_id=394172&lang=en)
- [A nurse provides anticipatory guidance about infant sleep. For each caregiver statement or…](https://mymerci.kr/pages/nclex_q.php?qn_id=395663&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=617238&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=617238&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=617238&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=617238&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=617238&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._

